Loading…
Novelix Pharmaceuticals (BSE 536565)₹63.24−2.20%Healthcare Research, Analytics & Technology
At the end of the Sep 2026 quarter, Novelix Pharmaceuticals' shareholders were: promoters 54.35%, public 45.65%. Promoter holding is up 3.72 percentage points from 50.63% a quarter earlier. 0.00% of promoter shares were pledged. It had 3,126 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.98% | 66.98% | 66.60% | 66.62% | 66.62% | 66.62% | 52.81% | 53.39% | 52.03% | 49.49% | 50.63% | 54.35% |
| Public | 33.02% | 33.02% | 33.40% | 33.38% | 33.38% | 33.38% | 47.19% | 46.61% | 47.97% | 50.51% | 49.37% | 45.65% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 2,620 | 2,634 | 2,568 | 2,532 | 2,501 | 2,483 | 2,407 | 2,696 | 2,993 | 2,974 | 3,117 | 3,126 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Srinidhi Fine-Chemicals Llp | Promoter | 35.09% | +2.06 |
| Vupparapalli Chandrasekhar Reddy | Promoter | 10.20% | +1.29 |
| Mallela Venkatramna Reddy | Public | 6.44% | −1.23 |
| Narhari Belide | Promoter | 4.24% | +0.86 |
| Sesha Sai Nikhil Chintalapati | Public | 3.41% | −0.65 |
| Srinivasrao Swetha Kanakapur | Public | 3.06% | −0.58 |
| Vupparapalli Pavani | Promoter | 2.54% | −0.48 |
| Panchagnula Venkata Lakshmi Narayana Sankara Vara Prasad | Public | 2.19% | −0.42 |
| Palakurthi Rakesh | Public | 2.00% | −0.38 |
| Gattu Gnana Prakash | Promoter | 1.41% | −0.27 |
| Arati Gattu | Promoter | 0.35% | −0.07 |
| Neha Gattu | Promoter | 0.35% | New |
| Shyam Agarwal (HUF) | Promoter | 0.09% | −0.01 |
| Soura Investments Holdings Private Limited | Public | Exited | — |
| Dm Fincon Services Llp | Public | Exited | — |
Promoters held 54.35% of Novelix Pharmaceuticals at the end of the Sep 2026 quarter, up 0.96 percentage points from 53.39% a year earlier.
No. The Sep 2026 filing shows no pledged promoter shares.
Novelix Pharmaceuticals had 3,126 shareholders at the end of the Sep 2026 quarter, against 2,696 a year earlier.
Mallela Venkatramna Reddy (Public) held 6.44% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.